Ledipasvir/sofosbuvir
id:
ledipasvir-sofosbuvir-274-721405
title:
Ledipasvir/sofosbuvir
text:
Ledipasvir/sofosbuvir, sold under the trade name Harvoni among others, is a medication used to treat hepatitis C. It is a fixed-dose combination of ledipasvir and sofosbuvir. Cure rates are 94% to 99% in people infected with hepatitis C virus (HCV) genotype 1. Some evidence also supports use in HCV genotype 3 and 4. It is taken daily by mouth for 8–24 weeks. It is generally well tolerated. Common side effects include muscle pains, headache, nausea, rash, and cough. It is unclear if use in pregna
brand slug:
wiki
category slug:
encyclopedia
description:
Medication used to treat hepatitis C
original url:
https://en.wikipedia.org/wiki/Ledipasvir/sofosbuvir
date created:
date modified:
2024-01-06T13:18:40Z
main entity:
{"identifier":"Q19597688","url":"https://www.wikidata.org/entity/Q19597688"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/f1/Ledipasvir_and_sofosbuvir.svg","width":512,"height":271}
fields total:
13
integrity:
15